|
Emcure
launches Emtri suspension for HIV affected kids
Emcure Pharmaceuticals Limited, one of India’s leading and
fast growing pharmaceutical company has launched Emtri Suspension
— a paediatric combination of three drugs namely lamivudine,
stavudine and nevirapine for children infected with HIV/AIDS.
Orchid
enters into pact with US-based STADA Pharmaceuticals
The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals
Ltd (Orchid), has entered into an exclusive agreement with STADA
Pharmaceuticals Inc, the US subsidiary of STADA Arzneimittel AG,
for the development and supply of six prescription generic drug
products to STADA for the US market.
Glenmark’s
Brazilian subsidiary acquires Uno-Ciclo for USD 4.6 million
Glenmark Farmaceutica Ltda (GFL), the wholly-owned Brazilian subsidiary
of Glenmark Pharmaceuticals Limited has purchased a leading hormonal
brand, Uno-Ciclo from Instituto Biochimico Indústria Farmaceutica
Ltda for USD 4.6 million.
Glaxo
gets board approval to buy back 25 per cent shares
GlaxoSmithKline Pharmaceuticals Ltd (GSK) said that it has decided
to go for a share buyback program of up to 25 per cent of the total
paid-up equity share capital and free reserves of the company.
|
